Attached herewith Financial Results for Fourth Quarter and Financial Year ended 31st March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Wardwizard Healthcare reported audited results for FY25 showing revenue from operations of just Rs 11.10 lakhs, a sharp 73% decline from Rs 41.70 lakhs in FY24, as the company wound down its old trading/mercantile business and pivoted into healthcare services starting July 2024. Net loss for FY25 widened to Rs 271.33 lakhs versus Rs 44.86 lakhs in FY24, with Q4 alone posting a loss of Rs 110.81 lakhs. The balance sheet expanded dramatically with total assets jumping from Rs 47.78 lakhs to Rs 874.11 lakhs, funded mainly by borrowings which surged to Rs 972 lakhs, pushing equity into deeply negative territory at Rs (311.29) lakhs. Operating cash flow was negative at Rs (163.45) lakhs, covered by fresh borrowings of Rs 229.68 lakhs. The statutory auditor issued an unmodified (clean) opinion, though it drew attention to the healthcare business commencement and pending/recently obtained licenses under the Drugs and Cosmetics Act and Gujarat Clinical Establishments Act.
The company is in a heavy investment and turnaround phase with deeply negative equity, rising debt, widening losses, and negative operating cash flow—risky for shareholders despite a clean audit opinion. Stock sentiment will depend on how quickly the newly launched healthcare segment ramps up revenues and starts reducing cash burn.